Healthcare provider profile · identity verified

Jacob J. Bryan, M.D.

Family Practice · SUN PRAIRIE, WI · NPI 1710114657

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	283	76
Atorvastatin Calcium	Atorvastatin Calcium	234	64
Omeprazole	Omeprazole	213	60
Lisinopril	Lisinopril	163	48
Metoprolol Succinate	Metoprolol Succinate	162	40
Losartan Potassium	Losartan Potassium	154	43
Rosuvastatin Calcium	Rosuvastatin Calcium	146	45
Hydrochlorothiazide	Hydrochlorothiazide	144	45
Levothyroxine Sodium	Levothyroxine Sodium	130	37
Eliquis	Apixaban	126	26
Gabapentin	Gabapentin	116	32
Sertraline Hcl	Sertraline Hcl	113	24
Pregabalin	Pregabalin	109	18
Metformin Hcl	Metformin Hcl	106	27
Metformin Hcl Er	Metformin Hcl	92	28
Trazodone Hcl	Trazodone Hcl	92	22
Furosemide	Furosemide	83	25
Simvastatin	Simvastatin	79	25
Famotidine	Famotidine	71	27
Tamsulosin Hcl	Tamsulosin Hcl	67	21
Trulicity	Dulaglutide	65	suppressed
Oxycodone Hcl	Oxycodone Hcl	63	12
Fluticasone Propionate	Fluticasone Propionate	61	23
Alendronate Sodium	Alendronate Sodium	60	20
Potassium Chloride	Potassium Chloride	58	21
Carvedilol	Carvedilol	57	14
Pantoprazole Sodium	Pantoprazole Sodium	57	16
Albuterol Sulfate Hfa	Albuterol Sulfate	55	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	15
Allopurinol	Allopurinol	53	13
Glipizide Er	Glipizide	51	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	11
Bupropion Xl	Bupropion Hcl	48	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	16
Pravastatin Sodium	Pravastatin Sodium	45	13
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Clonidine	Clonidine	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Baclofen	Baclofen	33	suppressed
Jardiance	Empagliflozin	33	11
Memantine Hcl	Memantine Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	19
Xarelto	Rivaroxaban	31	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Glipizide	Glipizide	28	suppressed
Irbesartan	Irbesartan	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Atenolol	Atenolol	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Diazepam	Diazepam	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Ozempic	Semaglutide	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Linzess	Linaclotide	19	suppressed
Prednisone	Prednisone	19	17
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Bumetanide	Bumetanide	18	suppressed
Cephalexin	Cephalexin	18	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Dapsone	Dapsone	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error